Wei-Lin Wang Selected Research

Wei-Lin Wang Research Topics

Disease

26	Neoplasms (Cancer) 10/2023 - 02/2004
8	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 08/2004
7	Anorectal Malformations 11/2018 - 01/2007
7	Infections 12/2015 - 02/2002
5	Thrombosis (Thrombus) 01/2016 - 02/2004
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2005
4	Fibrosis (Cirrhosis) 02/2021 - 11/2006
4	Hepatitis B 12/2011 - 08/2002
3	Liver Failure 02/2021 - 02/2004
3	Liver Neoplasms (Liver Cancer) 02/2018 - 06/2007
3	Hemorrhage 01/2018 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 08/2015
2	Carcinoma (Carcinomatosis) 10/2023 - 02/2003
2	Obesity 10/2021 - 12/2015
2	Diabetes Mellitus 10/2021 - 12/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 12/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2021 - 02/2018
2	Neural Tube Defects (Exencephaly) 01/2020 - 02/2019
2	Neurilemmoma (Schwannoma) 05/2017 - 10/2016
2	End Stage Liver Disease 12/2015 - 12/2011
2	Cataract (Cataracts) 11/2010 - 07/2010
2	Liver Diseases (Liver Disease) 09/2004 - 11/2002
2	Reinfection 11/2002 - 08/2002
1	Disease Progression 01/2023
1	Cholangiocarcinoma 01/2023
1	Varicose Veins (Varicose Vein) 08/2022
1	Postoperative Pain 08/2022
1	Pain (Aches) 08/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Fatty Liver 10/2021
1	Insulin Resistance 10/2021
1	Hepatopulmonary Syndrome 01/2020
1	Intraoperative Complications 01/2020
1	Liposarcoma 08/2019
1	Spina Bifida Cystica (Spina Bifida Aperta) 02/2019
1	Hypertrophy 02/2018

Drug/Important Bio-Agent (IBA)

4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2020 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 02/2019 - 02/2002
3	Messenger RNA (mRNA)IBA 11/2019 - 06/2005
3	Immunoconjugates (Immunoconjugate)IBA 04/2019 - 01/2018
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2018
2	AntigensIBA 12/2020 - 02/2002
2	Proteins (Proteins, Gene)FDA Link 02/2019 - 06/2014
2	EnzymesIBA 02/2019 - 02/2014
2	AntibodiesIBA 01/2019 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 06/2014 - 06/2007
2	EthylenethioureaIBA 04/2010 - 08/2008
1	VimentinIBA 10/2023
1	Sucrose (Saccharose)IBA 10/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023
1	pemigatinibIBA 01/2023
1	Anesthetics (Anesthetic Agents)IBA 08/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	BuffersIBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Complement C3 (C3 Complement)IBA 10/2021
1	Alanine Transaminase (SGPT)IBA 12/2020
1	Keratin-19 (Keratin 19)IBA 12/2020
1	NADPH Oxidase 4IBA 01/2020
1	CarbohydratesIBA 08/2019
1	Transaminases (Aminotransferases)IBA 08/2019
1	E 10 (E-10)IBA 02/2019
1	MethyltransferasesIBA 02/2019
1	hydrogen sulfite (bisulfite)IBA 02/2019
1	Olive OilIBA 02/2019
1	O-(6)-methylguanineIBA 02/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2019
1	A-Form DNA (A-DNA)IBA 02/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	ThioureaIBA 01/2018
1	CarcinogensIBA 01/2018
1	ethyleneIBA 01/2018
1	S100 Proteins (S 100 Protein)IBA 05/2017
1	Ethanol (Ethyl Alcohol)IBA 12/2016
1	Capsules (Microcapsules)IBA 07/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016

Therapy/Procedure

24	Liver Transplantation 01/2020 - 02/2002
10	Therapeutics 02/2024 - 12/2010
6	Transplantation 12/2015 - 05/2002
4	Pancreaticoduodenectomy 05/2018 - 08/2015
3	Hepatectomy 02/2021 - 02/2018
3	Pancreatectomy 05/2017 - 11/2014
3	Laparotomy 08/2016 - 08/2008
3	Lenses 11/2010 - 04/2007
2	Palliative Care (Palliative Therapy) 01/2017 - 08/2004
2	Conservative Treatment 09/2004 - 02/2004
2	Thrombectomy 09/2004 - 02/2004
1	Punctures 08/2022
1	Radiofrequency Ablation 08/2022
1	Anesthesia 08/2022
1	Injections 08/2022
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 01/2020
1	Patient Readmission 01/2020
1	Chemoradiotherapy 01/2020
1	Microspheres (Microsphere) 01/2017
1	Brachytherapy 12/2016
1	Radiotherapy 12/2016